Glucotrack (GCTK) Non-Current Debt (2024 - 2025)

Glucotrack's (GCTK) quarterly Non-Current Debt came in at $227000.0 in Q3 2025, up 2.71% on a QoQ basis from $221000.0 in Q2 2025.

Glucotrack (GCTK) Non-Current Debt (2024 - 2025) Analysis & Trends

Glucotrack (GCTK) has 2 years of Non-Current Debt data on file, last reported at $227000.0 in Q3 2025.

Quarterly Non-Current Debt changed N/A year-over-year to $227000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $227000.0 (changed N/A YoY) and the FY2024 annual result came in at $203000.0, changed N/A from the prior year.
Non-Current Debt climbed to $227000.0 in Q3 2025, from $221000.0 in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $227000.0 in Q3 2025 to a low of $201000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Intuitive Surgical	134.22 Bn	129.00 Bn	1.96 Bn	-
2	Becton Dickinson	52.42 Bn	51.56 Bn	2.32 Bn	13.51 Bn
3	Alcon	35.74 Bn	34.39 Bn	1.68 Bn	4.15 Bn
4	Resmed	33.89 Bn	32.42 Bn	861.22 Mn	399.42 Mn
5	Medline	28.89 Bn	26.21 Bn	2.22 Bn	12.55 Bn
6	West Pharmaceutical Services	25.07 Bn	24.64 Bn	329.20 Mn	202.90 Mn
7	Solventum	15.30 Bn	14.90 Bn	1.29 Bn	4.57 Bn
8	Cooper Companies	14.83 Bn	14.69 Bn	735.40 Mn	1.86 Bn
9	Baxter International	13.62 Bn	11.47 Bn	1.03 Bn	8.62 Bn
10	Glucotrack	1.75 Mn	629,179.72	-	248,000.00

Download Data